Study of Sacituzumab Govitecan Combinations in First-line Treatment of Participants With Advanced or Metastatic Non-Small-Cell Lung Cancer (NSCLC)
Running, not enrolling · Phase 2
Conditions studied: Non-small Cell Lung Cancer
In brief
The goal of this clinical study is to learn more about the study drug, sacituzumab govitecan-hziy (SG), and its dosing in combination with pembrolizumab or pembrolizumab and a platinum agent (carboplatin or cisplatin), in participants with advanced or metastatic (cancer that has spread) non-small-cell lung cancer (NSCLC).
Key facts
- Study ID
- NCT05186974
- Run by
- Gilead Sciences
- People needed
- 193
- Starts
- 2022-05-30
- Expected to finish
- 2026-09-01
- Last updated by the study team
- 2026-02-11
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
Where it is running
- Beverly Hills Cancer Center — Beverly Hills, California, United States
- USC/Norris Comprehensive Cancer Center — Los Angeles, California, United States
- UCLA Hematology/Oncology - Santa Monica — Los Angeles, California, United States
- UC Irvine Health — Orange, California, United States
- Stanford Cancer Institute — Stanford, California, United States
- University of Colorado Hospital - Anschutz Cancer Pavilion (ACP) — Aurora, Colorado, United States
- Georgetown University Medical Center — Washington D.C., District of Columbia, United States
- Moffitt Cancer Center — Tampa, Florida, United States
- Northside Hospital Central Research Department — Atlanta, Georgia, United States
- Northwestern Memorial Hospital — Chicago, Illinois, United States
- Rush University Medical Center — Chicago, Illinois, United States
- Orchard Healthcare Research Inc. — Skokie, Illinois, United States
- Kansas City Veterans Affairs Medical Center — Westwood, Kansas, United States
- Kansas City VA Medical Center — Kansas City, Missouri, United States
- Weill Cornell Medical/New York-Presbyterian Hospital — New York, New York, United States
- Great Lakes Cancer Care — Williamsville, New York, United States
- Wake Forest Baptist Health - High Point Medical Center — High Point, North Carolina, United States
- FirstHealth Outpatient Cancer Center — Pinehurst, North Carolina, United States
- University Hospital Cleveland Medical Center — Cleveland, Ohio, United States
- OSU Brain & Spine Hospital — Columbus, Ohio, United States
- Siouxland Regional Cancer Center dba June E. Nylen Cancer Center — North Sioux City, South Dakota, United States
- Southern Highlands Cancer Centre — Bowral, New South Wales, Australia
- Saint Vincents Hospital Sydney — Darlinghurst, New South Wales, Australia
- St George Private Hospital — Kogarah, New South Wales, Australia
- Alaska Oncology and Hematology, LLC. — Anchorage, Alaska, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.